Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLSD Clearside Biomedical Inc.

未开盘 12-24 13:00:00 EST

0.9290

+0.0493

+5.60%

盘后0.9043

-0.0247-2.66%

16:58 EST

最高0.9400	最低0.8500	成交量56.77万
今开0.8928	昨收0.8797	日振幅10.23%
总市值7,046万	流通市值6,524万	总股本7,584万
成交额49.70万	换手率0.81%	流通股本7,022万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLSD","market":"US","secType":"STK","nameCN":"Clearside Biomedical Inc.","latestPrice":0.929,"timestamp":1735063200000,"preClose":0.8797,"halted":0,"volume":567736,"hourTrading":{"tag":"盘后","latestPrice":0.9043,"preClose":0.929,"latestTime":"16:58 EST","volume":1328,"amount":1217.5954,"timestamp":1735077485306},"delay":0,"floatShares":70221338,"shares":75843504,"eps":-0.456428,"marketStatus":"未开盘","marketStatusCode":0,"change":0.0493,"latestTime":"12-24 13:00:00 EST","open":0.8928,"high":0.94,"low":0.85,"amount":496981.957774,"amplitude":0.102308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.456428,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735203600000},"adr":0,"listingDate":1464840000000,"adjPreClose":0.8797,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.87,"preClose":0.8797,"latestTime":"09:29 EST","volume":3865,"amount":3342.94556,"timestamp":1735050590678},"postHourTrading":{"tag":"盘后","latestPrice":0.9043,"preClose":0.929,"latestTime":"16:58 EST","volume":1328,"amount":1217.5954,"timestamp":1735077485306},"volumeRatio":1.9716371103649906,"impliedVol":0.7689,"impliedVolPercentile":0.1865},"requestUrl":"/m/hq/s/CLSD/wiki","defaultTab":"wiki","newsList":[{"id":"2494329470","title":"Clearside Biomedical, Inc.盘中异动 快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494329470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494329470?lang=zh_cn&edition=full","pubTime":"2024-12-25 01:44","pubTimestamp":1735062291,"startTime":"0","endTime":"0","summary":"北京时间2024年12月25日01时44分，Clearside Biomedical, Inc.股票出现异动，股价大幅上涨5.23%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225014451ab90e264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225014451ab90e264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2492344428","title":"Clearside Biomedical, Inc.盘中异动 股价大跌12.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492344428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492344428?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:35","pubTimestamp":1734705307,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时35分，Clearside Biomedical, Inc.股票出现波动，股价快速跳水12.60%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 、Psyence Biomedical Ltd.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1769.12%、80.09%、55.09%，振幅较大的相关个股有Humacyte, Inc.、Quoin Pharmaceuticals Ltd、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为33.53%、30.92%、29.60%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223507ab876694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223507ab876694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2489614421","title":"Clearside Biomedical, Inc.盘中异动 大幅下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489614421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489614421?lang=zh_cn&edition=full","pubTime":"2024-12-05 04:41","pubTimestamp":1733344890,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日04时41分，Clearside Biomedical, Inc.股票出现异动，股价大幅下挫5.09%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205044130971baf8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205044130971baf8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2485294532","title":"Clearside Biomedical, Inc.盘中异动 大幅拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485294532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485294532?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:41","pubTimestamp":1732297278,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时41分，Clearside Biomedical, Inc.股票出现波动，股价快速上涨5.88%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、Sol-Gel Technologies Ltd.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1855.47%、151.14%、94.19%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Virpax Pharmaceuticals, Inc.，振幅分别为81.82%、75.32%、72.75%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014118971a826e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014118971a826e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2484066913","title":"Clearside Biomedical, Inc.2024财年第三财季实现净利润-7.69百万美元，同比增加17.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484066913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484066913?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010425,"startTime":"0","endTime":"0","summary":"11月19日，Clearside Biomedical, Inc.公布财报，公告显示公司2024财年第三财季净利润为-7.69百万美元，同比增加17.04%；其中营业收入为1.04百万美元，同比增加21.07%，每股基本收益为-0.10美元。从资产负债表来看，Clearside Biomedical, Inc.总负债63.95百万美元，其中短期债务373000.00美元，资产负债比为0.46，流动比率为4.50。机构评级：截至2024年11月19日，当前有7家机构对Clearside Biomedical, Inc.目标价做出预测，其中目标均价为6.00美元，其中最低目标价为5.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180136a24562a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180136a24562a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD"],"gpt_icon":0},{"id":"2483585786","title":"Clearside Biomedical, Inc.盘中异动 下午盘快速下跌5.71%报0.990美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483585786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483585786?lang=zh_cn&edition=full","pubTime":"2024-11-16 02:39","pubTimestamp":1731695970,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日02时39分，Clearside Biomedical, Inc.股票出现异动，股价大幅下跌5.71%。截至发稿，该股报0.990美元/股，成交量34.5593万股，换手率0.46%，振幅6.28%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为3.59%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111602393098e43042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111602393098e43042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2483889598","title":"Clearside Biomedical Inc 报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483889598","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483889598?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:27","pubTimestamp":1731508020,"startTime":"0","endTime":"0","summary":"   * Clearside Biomedical Inc   报告本季度调整后每股亏损10美分，高于去年同期的每股-15美分。七位分析师对该季度的平均预期是每股亏损 12 美分。* Clearside Biomedical Inc公布的本季度每股收益为亏损10美分。* 该公司的季度亏损额为 769 万美元。* Clearside Biomedical Inc的股价本季度下跌了12.6%，今年迄今为止下跌了5.1%。11月13日 - 预测变化   * 在过去三个月中，分析师的平均盈利预期上升了约 3.1%。华尔街对 Clearside Biomedical Inc 的 12 个月目标价中位数为 6.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Clearside Biomedical Inc 报告本季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2482908946","title":"Clearside Biomedical, Inc.盘中异动 早盘大幅上涨5.50%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482908946","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482908946?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:01","pubTimestamp":1731423718,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时01分，Clearside Biomedical, Inc.股票出现波动，股价大幅上涨5.50%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112230158971a6095&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112230158971a6095&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2482737533","title":"Clearside Biomedical, Inc.盘中异动 大幅下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482737533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482737533?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:30","pubTimestamp":1731342626,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时30分，Clearside Biomedical, Inc.股票出现异动，股价急速下挫5.17%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112003026971a5c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112003026971a5c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2482496459","title":"Clearside Biomedical Inc 预计每股亏损12美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482496459","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482496459?lang=zh_cn&edition=full","pubTime":"2024-11-09 05:40","pubTimestamp":1731102009,"startTime":"0","endTime":"0","summary":"Clearside Biomedical Inc 预计每股亏损12美分 - 财报前瞻Clearside Biomedical Inc CLSD.OQ CLSD.O将于11月12日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。根据LSEG的数据，7位分析师的平均预期显示，这家总部位于佐治亚州Alpharetta的公司的营收预计将从去年同期的85.9万美元下降85.7%，至12.286万美元。LSEG 分析师对 Clearside Biomedical Inc 的平均预期是每股亏损 12 美分。华尔街对 Clearside Biomedical Inc 的 12 个月目标价中位数为 6.00 美元，高于其最新收盘价 1.11 美元。11月8日 - 上一季度业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF2P0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSD"],"gpt_icon":0},{"id":"2479523747","title":"Clearside Biomedical, Inc.盘中异动 下午盘股价大跌5.45%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479523747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479523747?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:59","pubTimestamp":1730224742,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日01时59分，Clearside Biomedical, Inc.股票出现异动，股价急速下跌5.45%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103001590298e3f2aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103001590298e3f2aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2477365607","title":"Clearside Biomedical, Inc.盘中异动 早盘大幅跳水5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477365607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477365607?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:27","pubTimestamp":1729783656,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时27分，Clearside Biomedical, Inc.股票出现波动，股价大幅下挫5.73%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024232736971a21a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024232736971a21a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2477538421","title":"Clearside Biomedical, Inc.盘中异动 早盘快速下挫6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538421?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:38","pubTimestamp":1729690694,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时38分，Clearside Biomedical, Inc.股票出现波动，股价大幅下挫6.33%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321381498e3dfea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321381498e3dfea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2477332798","title":"Clearside Biomedical, Inc.盘中异动 早盘股价大跌6.06%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477332798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477332798?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:37","pubTimestamp":1729604251,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时37分，Clearside Biomedical, Inc.股票出现波动，股价急速跳水6.06%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Genprex, Inc.、Ensysce Biosciences, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为2436.50%、1430.22%、1327.16%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Ensysce Biosciences, Inc.、Genprex, Inc.，振幅分别为67.84%、58.11%、47.02%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213732971a19a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213732971a19a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2477637708","title":"Clearside Biomedical, Inc.盘中异动 早盘快速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477637708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477637708?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:40","pubTimestamp":1729518027,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时40分，Clearside Biomedical, Inc.股票出现波动，股价大幅上涨5.22%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.涨幅较大，Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.较为活跃，换手率分别为1997.62%、922.22%、451.73%，振幅较大的相关个股有Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.，振幅分别为84.48%、71.91%、44.26%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121402798e3d865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121402798e3d865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLSD","BK4007"],"gpt_icon":0},{"id":"2475362253","title":"Clearside Biomedical, Inc.盘中异动 股价大跌6.45%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475362253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475362253?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:39","pubTimestamp":1728913197,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时39分，Clearside Biomedical, Inc.股票出现波动，股价急速下跌6.45%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213957971a017f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213957971a017f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2474470092","title":"Clearside Biomedical, Inc.盘中异动 早盘快速下挫5.37%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474470092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474470092?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:48","pubTimestamp":1728654510,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时48分，Clearside Biomedical, Inc.股票出现异动，股价急速下挫5.37%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011214830a1e00308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011214830a1e00308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2474746391","title":"Clearside Biomedical, Inc.盘中异动 股价大涨6.15%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474746391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474746391?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:30","pubTimestamp":1728567054,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时30分，Clearside Biomedical, Inc.股票出现异动，股价快速拉升6.15%。Clearside Biomedical, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Clearside Biomedical, Inc.公司简介：Clearside Biomedical Inc 是一家总部位于美国的临床生物制药公司，致力于开发通过脉络膜上腔或 SCS 治疗眼部致盲疾病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102130559719f803&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102130559719f803&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CLSD"],"gpt_icon":0},{"id":"2474766020","title":"美国研究综述-雅培、吉利德、Roku","url":"https://stock-news.laohu8.com/highlight/detail?id=2474766020","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474766020?lang=zh_cn&edition=full","pubTime":"2024-10-10 14:40","pubTimestamp":1728542405,"startTime":"0","endTime":"0","summary":"    路透10月10日 - 华尔街证券分析师周四调整了对雅培、吉利德和 Roku 等多家美国上市公司的评级和目标价。要闻              * 雅培  ：摩根大通将目标价从125美元上调至135美元             * 吉利德  ：Raymond James将目标价从94美元上调至95美元             * Roku Inc   ：摩根大通将目标价从90美元上调至92美元 以下是路透周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1523d58f834c74cc4566ae08caad5895","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008368304.USD","LU0321505868.SGD","LU0321505439.SGD","LU1121112475.USD","SG9999018857.SGD","IE00BJJMRZ35.SGD","ACCD","BK4082","LU1043141396.HKD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1585245621.USD","LU0256863811.USD","LU1989772840.SGD","LU1035775433.USD","LU0868494617.USD","LU1989764664.SGD","LU1989772923.USD","IE00B19Z3581.USD","MCO","LU0158827948.USD","LU1023059063.AUD","LU0994945656.USD","LU2125154778.USD","SPGI","LU1066051498.USD","IBM","LU0320765992.SGD","LU2237438978.USD","COST","LU0058720904.USD","LU1043141123.HKD","LU1430594728.SGD","LU1571399168.USD","TXG","GILD","LU1057294990.SGD","ABT","OMF","LU1989763690.USD","SGXZ31699556.SGD","LU0122379950.USD","LU0471298777.SGD","LU1989773731.SGD","LU1914381329.SGD","LU1989763427.SGD","CLSD","LU1989764748.USD","LU0266013472.USD","ROKU"],"gpt_icon":0},{"id":"2474759162","title":"BUZZ--美国股票走势-波音、万岁、挪威邮轮公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2474759162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474759162?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:19","pubTimestamp":1728490759,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月9日 - 周三，美国股市在波澜不惊的交易中涨跌不一，投资者在等待美联储最近一次会议的纪要，而Alphabet股价在美国表示考虑拆分谷歌之后出现下滑。标普500指数  上涨0.58%，报5,784.65点；纳斯达克综合指数  上涨0.42%，报18,259.404点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430597077.USD","DKL","HMY","LU0868494617.USD","IE0034235303.USD","NEM","LU1435385759.SGD","SG9999001176.USD","LU0368265764.SGD","NYT","BK4023","BK4520","SG9999003800.SGD","LU0498741114.HKD","BK4574","BK4534","GTLB","LU1988902786.USD","CAT","LU0170899867.USD","VST","IE00B19Z3B42.SGD","IDT","LU2023250504.SGD","RDDT","BNZI","IE0034235188.USD","WW","BK4533","RIVN","MDLZ","AU","LU0321505439.SGD","LU0061474960.USD","ALTM","LU0056508442.USD","IE0002270589.USD","LU1057294990.SGD","CLSD","LU0096362180.USD","LU0158827948.USD","NCLH","PCAR","LU1066051498.USD","PFE","IE00B19Z3581.USD","LU2237438978.USD","BA","LU0211328371.USD","BK4149"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.clearsidebio.com","stockEarnings":[{"period":"1week","weight":-0.0892},{"period":"1month","weight":-0.1398},{"period":"3month","weight":-0.1705},{"period":"6month","weight":-0.2742},{"period":"1year","weight":-0.1067},{"period":"ytd","weight":-0.206}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Clearside Biomedical, Inc.于2011年5月26日在特拉华州注册成立。该公司是一个后期临床生物制药公司，开发先入类药物疗法来治疗眼睛的致盲疾病。公司目前的候选产品着力解决影响视网膜和脉络膜，尤其是黄斑水肿相关的疾病，并注入到使用其专有的SCS微量注射器脉络膜上腔。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.04293},{"month":2,"riseRate":0.5,"avgChangeRate":-0.031824},{"month":3,"riseRate":0.5,"avgChangeRate":0.06208},{"month":4,"riseRate":0.5,"avgChangeRate":-0.011671},{"month":5,"riseRate":0.25,"avgChangeRate":-0.080267},{"month":6,"riseRate":0.75,"avgChangeRate":0.163204},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.038074},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.074112},{"month":9,"riseRate":0.444444,"avgChangeRate":0.150007},{"month":10,"riseRate":0.333333,"avgChangeRate":0.04158},{"month":11,"riseRate":0.555556,"avgChangeRate":-0.029261},{"month":12,"riseRate":0.333333,"avgChangeRate":0.04632}],"exchange":"NASDAQ","name":"Clearside Biomedical Inc.","nameEN":"Clearside Biomedical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Clearside Biomedical Inc.,CLSD,Clearside Biomedical Inc.股票,Clearside Biomedical Inc.股票老虎,Clearside Biomedical Inc.股票老虎国际,Clearside Biomedical Inc.行情,Clearside Biomedical Inc.股票行情,Clearside Biomedical Inc.股价,Clearside Biomedical Inc.股市,Clearside Biomedical Inc.股票价格,Clearside Biomedical Inc.股票交易,Clearside Biomedical Inc.股票购买,Clearside Biomedical Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Clearside Biomedical Inc.(CLSD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Clearside Biomedical Inc.(CLSD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}